A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact

In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.

Detalles Bibliográficos
Autores principales: Marseille, Elliot, Kahn, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886960/
https://www.ncbi.nlm.nih.gov/pubmed/27243461
http://dx.doi.org/10.1371/journal.pmed.1002031
Descripción
Sumario:In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.

Ejemplares similares